David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Badger Meter
BMI
$3.94B
| $249K | ﹤0.01% |
4,649
-106
| -2% | -$6.46K |
|
|
CVET
3477
DELISTED
Covetrus, Inc. Common Stock
CVET
| $248K | ﹤0.01% |
30,497
+2,696
| +10% | +$30.8K |
|
|
MNDT
3478
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $248K | ﹤0.01% |
23,400
-186,600
| -89% | -$2.68M |
|
|
PLAN
3479
CALL
DELISTED
Anaplan, Inc.
PLAN
| $248K | ﹤0.01% |
8,200
| – | – |
|
|
CNCE
3480
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $247K | ﹤0.01% |
27,932
-12,499
| -31% | -$123K |
|
3481
Tompkins Financial
TMP
$1.41B
| $246K | ﹤0.01% |
+3,431
| New | +$284K |
|
|
COHR
3482
PUT
DELISTED
Coherent Inc
COHR
| $245K | ﹤0.01% |
+2,300
| New | +$322K |
|
3483
Afya
AFYA
$1.26B
| $244K | ﹤0.01% |
12,788
-111
| -0.9% | -$2.75K |
|
3484
Boot Barn
BOOT
$4.9B
| $244K | ﹤0.01% |
+18,899
| New | +$603K |
|
|
ESGR
3485
DELISTED
Enstar Group
ESGR
| $244K | ﹤0.01% |
1,537
+33
| +2% | +$6.05K |
|
3486
Ameriprise Financial
AMP
$49.6B
| $243K | ﹤0.01% |
+2,368
| New | +$351K |
|
|
BCPC
3487
Balchem Corp
BCPC
$5.66B
| $243K | ﹤0.01% |
2,466
-11,395
| -82% | -$1.17M |
|
3488
First Citizens BancShares
FCNCA
$24.7B
| $242K | ﹤0.01% |
727
-6,528
| -90% | -$3.02M |
|
3489
Helios Technologies
HLIO
$2.44B
| $242K | ﹤0.01% |
6,387
-3,667
| -36% | -$156K |
|
3490
PUT
Puma Biotechnology
PBYI
$471M
| $239K | ﹤0.01% |
28,300
-60,000
| -68% | -$583K |
|
|
EVV
3491
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $238K | ﹤0.01% |
+22,500
| New | +$279K |
|
3492
Rithm Capital
RITM
$5.72B
| $238K | ﹤0.01% |
47,530
-534,969
| -92% | -$7.75M |
|
3493
ResMed
RMD
$33.5B
| $238K | ﹤0.01% |
1,614
+200
| +14% | +$31.9K |
|
3494
Haverty Furniture Companies
HVT
$430M
| $237K | ﹤0.01% |
19,896
-16,748
| -46% | -$295K |
|
3495
Shenandoah Telecom
SHEN
$681M
| $237K | ﹤0.01% |
4,813
-14,896
| -76% | -$662K |
|
|
BRSP
3496
BrightSpire Capital
BRSP
$621M
| $233K | ﹤0.01% |
+59,226
| New | +$649K |
|
3497
Future Fuel
FF
$241M
| $233K | ﹤0.01% |
20,663
+3,428
| +20% | +$38.1K |
|
3498
MGP Ingredients
MGPI
$384M
| $233K | ﹤0.01% |
8,671
-141,476
| -94% | -$4.83M |
|
|
PHK
3499
PIMCO High Income Fund
PHK
$848M
| $233K | ﹤0.01% |
+47,500
| New | +$323K |
|
|
CLVS
3500
DELISTED
Clovis Oncology, Inc.
CLVS
| $233K | ﹤0.01% |
36,567
-389,964
| -91% | -$3.13M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.